Overview

Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether olanzapine, compared to risperidone, can provide more adequate and timely control of behavioral agitation in acutely ill subjects with schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Antipsychotic Agents
Olanzapine
Risperidone